Historical Stock Price
ETFs Holding HEB »    HEB Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/26/2019 $1.92 $2.00 $1.87 $1.87 22.80K
08/27/2019 $1.87 $1.99 $1.83 $1.87 38.60K
08/28/2019 $1.89 $1.90 $1.81 $1.86 11.90K
08/29/2019 $1.94 $1.94 $1.78 $1.81 31.10K
08/30/2019 $1.97 $1.97 $1.78 $1.80 14.70K
AIM ImmunoTech is a pharmaceutical company. Co. is engaged in the development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Co.'s primary products include: Alferon N Injection® and the experimental therapeutic Ampligen®. Alferon N Injection® is approved for a category of sexually transmitted disease infection, and Ampligen® represents an experimental RNA being developed for viral diseases and disorders of the immune system. Co.'s platform technology includes components for potential treatment of various severely debilitating and life threatening diseases.
HEB historical stock prices picture
HEB (HEB) has the following price history information. Looking back at HEB historical stock prices for the last five trading days, on August 26, 2019, HEB opened at $1.92, traded as high as $2.00 and as low as $1.87, and closed at $1.87. Trading volume was a total of 22.80K shares. On August 27, 2019, HEB opened at $1.87, traded as high as $1.99 and as low as $1.83, and closed at $1.87. Trading volume was a total of 38.60K shares. On August 28, 2019, HEB opened at $1.89, traded as high as $1.90 and as low as $1.81, and closed at $1.86. Trading volume was a total of 11.90K shares. On August 29, 2019, HEB opened at $1.94, traded as high as $1.94 and as low as $1.78, and closed at $1.81. Trading volume was a total of 31.10K shares. On August 30, 2019, HEB opened at $1.97, traded as high as $1.97 and as low as $1.78, and closed at $1.80. Trading volume was a total of 14.70K shares.

HEB Historical Stock Prices By Date:

HEB historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into HEB shares, starting with a $10,000 purchase of HEB, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/12/2010
End date: 08/30/2019
Start price/share: $258.72
End price/share: $1.80
Dividends collected/share: $0.00
Total return: -99.30%
Average Annual Total Return: -41.93%
Starting investment: $10,000.00
Ending investment: $69.60
Years: 9.14
Date Close
08/26/2019$1.87
08/27/2019$1.87
08/28/2019$1.86
08/29/2019$1.81
08/30/2019$1.80
HEB is categorized under the Healthcare sector; below are some other companies in the same sector:

HGR Historical Stock Prices
HH Historical Stock Prices
HITK Historical Stock Prices
HLS Historical Stock Prices
HMA Historical Stock Prices
HMSY Historical Stock Prices
HNSN Historical Stock Prices
HNT Historical Stock Prices
HOLX Historical Stock Prices
HPTX Historical Stock Prices

HEB Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.